Resistance to blood-stage malaria in AcB55 and AcB61 is caused by a loss of function mutation in pyruvate kinase (Pklr I90N ). Likewise, pyruvate kinase (PK) deficiency in humans is protective against Plasmodium replication in vitro. We identified a third AcB strain, AcB62 that also carries the Pklr I90N mutation. However, AcB62 mice were susceptible to P.chabaudi infection and showed high levels of parasite replication (54-62% peak parasitemia). AcB62 mice showed the hallmarks of PK deficiencyassociated anemia similar to AcB55/61 with reticulocytosis, splenic red pulp expansion, tissue iron overload, and increased expression of iron metabolism proteins. This suggests that malaria susceptibility in AcB62 is not because of absence of PK deficiency-associated pathophysiology. To map novel genetic factors affecting malaria susceptibility in AcB62, we generated an informative F2 population using AcB62 (Pklr I90N ) and CBA-Pk slc (Pklr G338D ) as progenitors and identified a novel locus on chromosome 9 (Char10; LOD ¼ 7.24) that controls peak parasitemia. A weaker linkage to the Pklr region of chromosome 3 (LOD ¼ 3.7) was also detected, a finding that may reflect the segregation of the two defective Pklr alleles. AcB62 alleles at both loci are associated with higher peak parasitemia. These results identify Char10 as a novel locus modulating severity of malaria in the context of PK deficiency.
Introduction
Malaria is a widespread infectious disease that continues to be a major public health problem, despite large-scale control efforts. A strong genetic basis for disease susceptibility is clear in malaria; genetic factors have a key function in the onset, progression, type of disease developed, and ultimate outcome of infection with Plasmodium parasites. 1, 2 Evidence suggests that over the course of thousands of years, the malarial parasite has exerted strong genetic pressure on the human genome. 3 This is most notable in populations living in malaria endemic and hyper-endemic regions, where otherwise deleterious mutant alleles causing a variety of red cell disorders are present at unusually high frequencies because of the protection they offer against malaria. 4 Such malaria-protective erythrocyte disorders include hemoglobinopathies such as sickle cell (HbS) or thalassemia, as well as mutations in other erythrocyte proteins, including the anion exchanger AE1 (Band3/SLC4A1), the Duffy antigen and glucose-6-phosphate dehydrogenase (reviewed in Williams 4 , Min-Oo and Gros
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) Aside from these well-known erythrocyte-specific variants, linkage and association studies with candidate genes in humans have suggested a large number of additional genetic effects, implying that the genetic component of susceptibility to malaria is very complex. 2, 6 We, and others, have used a mouse model of bloodstage infection with P. chabaudi AS to study the genetic control of susceptibility to malaria in mice. Studies in inbred and recombinant congenic mouse strains have mapped several major Chabaudi resistance loci (Char1-Char9) that control the extent of P. chabaudi replication in the blood at the peak of infection (peak parasitemia) and affect overall survival (reviewed in Fortin et al. 7 and Hernandez-Valladares et al. 8 ). Most of these quantitative trait loci (QTLs) are defined by large chromosomal regions (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) and account for only a fraction of the phenotypic variance, making it difficult to identify the gene(s) involved. We have used a set of 36 AcB/BcA recombinant congenic strains, derived from susceptible A/J and resistant C57BL/6J (B6) progenitors and generated by two backcrosses followed by inbreeding, to dissect the complex genetic control of differential susceptibility to P.chabaudi in these two strains. These recombinant congenic strains carry 12.5% of the donor strain on the background (87.5%) of the acceptor strain, with the donor genomic contribution fixed as a discrete set of small congenic segments that have been mapped by genotyping. 9 Using these strains we mapped the Char9 susceptibility locus to a 14 Mb B6-derived segment on chromosome 10. Susceptibility was shown to result from loss-of-function at the Vnn3 gene. 10 The loss of Vnn3-encoded pantetheinase enzymatic activity could be corrected by passive administration of the pantetheinase pathway product, cysteamine, which corrected susceptibility to P. chabaudi in A/J mice. 10 We also identified two AcB strains, namely AcB55 and AcB61, that displayed an unusually high degree of resistance to P. chabaudi, despite their A/J background and presence of A/J-derived susceptibility alleles at Char1 and Char2. 7 Resistance is phenotypically expressed as low levels of peak parasitemia and uniform survival to infection. AcB55/AcB61 show signs of anemia even in the absence of P. chabaudi infection, manifested by splenomegaly, extramedullary erythropoiesis, and high levels of reticulocytes in the peripheral blood. 11 Using parasitemia and reticulocyte levels as quantitative traits in informative F2 populations derived from AcB55/ AcB61, a major locus (Char4) was identified that controlled both traits and mapped to the same segment of Chr. 3.
12,13 The Char4 effect was subsequently shown to be caused by a loss-of-function mutation in the Pklr gene (Pklr I90N ), which occurred on the A/J-derived background during the generation of AcB55/61. 13 Pklr encodes the liver and erythrocyte-specific form of the enzyme pyruvate kinase (PK), which has a critical function in ATP generation from glycolysis in erythrocytes.
14 A second severe loss-of-function allele at Pklr (Pklr
G338D
), which arose on a CBA/N genetic background (CBA/N-Pk slc ), 15 was also shown to confer resistance to P. chabaudi infection. 16 These results showed that PK deficiency in mice has a protective effect against bloodstage malaria. In humans, PK deficiency is the most frequent abnormality of the glycolytic pathway and, together with a deficiency in glucose-6-phosphate dehydrogenase, is the most common cause of non-spherocytic hemolytic anemia.
14 Recently, we have shown that PK deficiency has a protective effect against replication of P. falciparum parasites in human erythrocytes in vitro.
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Erythrocytes from individuals with clinical PK deficiency and homozygous for mutations in PKLR, exhibited decreased invasion through three cycles of growth of either chloroquine-sensitive or resistant P. falciparum isolates. In addition, a substantial increase in phagocytic uptake by human and mouse macrophages was observed for homozygous and heterozygous PKLR mutant erythrocytes infected with early, ring-stage parasites. 17 In this study, we report the identification of a third AcB mouse strain, AcB62, which carries the defective Pklr I90N . Intriguingly, and unlike AcB55/AcB61, AcB62 are susceptible to malaria and show very high levels of peak parasitemia after infection with P. chabaudi. We have characterized the PK deficiency phenotype of AcB62 and used whole genome scanning in informative crosses to identify a major locus on chromosome 9 that influences malaria susceptibility in the context of PK deficiency.
Materials and methods
Mice and parasite A/J and C57BL/6J mice were purchased from the Jackson Laboratories (Bar Harbor, ME, USA). The AcB/ BcA panel of recombinant congenic strains was generated according to a breeding scheme described by Demant and Hart, 18 and has been genotyped for over 600 informative markers. 9 AcB55, AcB61, and AcB62 strains were obtained as breeding pairs from Emerillon Therapeutics (Montreal, Canada), CBA-Pk slc was generously provided by the Japan SLC Animal Facility (Mr H Asai); all strains were subsequently maintained as breeding colonies at McGill University. All mice were maintained and handled according to guidelines of the Canadian Council on Animal Care. An LDH virus-free isolate of P. chabaudi AS, originally obtained from Dr D Walliker (University of Edinburgh), was maintained by weekly passage in A/J mice by i.p infection with 10 6 parasitized red blood cells (pRBC) suspended in 1 ml of pyrogen-free saline. After infection, the percentage of pRBC was determined daily on thin blood smears stained with Dif-Quick (American Scientific Products, McGraw Park, IL, USA) on days 4-28 post infection, as we have described earlier. 12 Mutation screening in AcB/BcA strains Genomic DNA was isolated from all AcB/BcA strains as described earlier. 9 Exon 2 of Pklr was amplified by PCR using specific oligos and standard conditions; 5 ml of PCR product was directly digested with SfAN1 (New England Biosciences, Ipswich, MA, USA) for 2-4 h at 37 1C. The digestion products were analyzed by agarose gel electrophoresis as the I90N mutation abolishes the SfAN1 restriction site. The presence of the I90N mutation in AcB62 was validated by sub-cloning Pklr exon 2 into a TOPO TA vector (Invitrogen, Burlington, ON), purification of the plasmid and standard dideoxynucleotide sequencing using 33 P-dATP, as described earlier. 13 Hematological and flow cytometry analysis Spleen and bone marrow cells were collected from A/J, AcB55, and AcB62 male mice for analysis by flow cytometry. Splenocytes were prepared as described. 19 Briefly, spleens were minced with scissors and pressed gently through a sterile fine wire mesh. Red blood cells were removed by incubation with NH 4 Cl lysing buffer. Bone marrow cells were collected by flushing the femur cavity with 2-3 ml of PBS. Cells collected from femurs were washed with PBS and enumerated by counting using a hemocytometer. Aliquots of 1 Â 10 6 cells per 50 ml were FcR blocked with anti-CD16/CD32 mAb (BD Biosciences, Mississauga, ON) before staining for flow cytometry. Early erythroblasts were differentially stained with FITC-conjugated CD71 mAb (BD Bioscience) and PE-conjugated TER119 mAb (BD Bioscience) and splenocytes were stained with PE-conjugated mAbs (BD Bioscience) against CD3. Cells were acquired using a FACSCalibur (BD Bioscience) and data were analyzed using CellQuest Pro software (BD Bioscience). Controls were included in each experiment in which cells were stained with PE-or FITC-conjugated isotype-matched irrelevant antibodies.
For hematological analysis, fresh whole blood was collected in heparinized tubes by cardiac puncture from three mice per strain. Complete blood count and differential were performed by the DRSS of the Animal Resources Center of McGill University. Reticulocyte counts were performed on methylene-blue-stained thin blood smears; 100 cells were counted per field in four fields.
Histology and iron studies Spleen and liver were obtained from A/J, AcB55, and AcB62 male mice (three per strain), fixed overnight in 10% formalin (neutral buffered), dehydrated in ethanol/xylene, and embedded in paraffin wax. Histological sections were cut on a microtome at 5 and 10 mM and fixed to glass slides. Sections were deparaffinized in xylene, rehydrated in a series of ethanol baths, and then stained with hematoxylin/eosin, dehydrated in ethanol/xylene, and mounted with Permount as described earlier.
11 Stained sections were examined under a light microscope at Â 100 ( Â 10 þ Â 10 objective) and photographed. Liver and spleen iron were measured at the Laboratory of Biochemistry at the Institut Fédé ratif de Recherche 02, CHU Bichat-Claude Bernard (Paris, France). Intracellular iron staining of sections of liver using Perl's solution was performed at the Plateau de Morphologie, Anatomie-Cytologie Pathologiques IFR02 as described earlier. 20 
Immunoblotting
The level of expression of several proteins of iron metabolism was measured in spleen and liver by immunoblotting. Briefly, crude membrane preparations were prepared from freshly frozen samples as described earlier. 21 Ferroportin, heme oxygenase 1, and the transferrin receptor (TFR) were detected using specific antisera and western blot protocols as we have described earlier. 21, 22 Immunoblotting against divalent metal transporter 1 (DMT1) was performed on whole organ extracts. Briefly, tissues were dounce homogenized in RIPA buffer and debris was removed by centrifugation. Equal amount of protein (80 mg) was separated by SDS-PAGE and transferred onto nitrocellulose. Membranes were incubated with affinity purified anti-DMT1 antibody, 23, 24 diluted in blocking solution (5% milk/TBST) to 1:500, followed by incubation with HRP-conjugated anti-rabbit IgG secondary antibody (1:20 000) and visualization by chemiluminescence (Pierce Scientific, Rockford, IL, USA).
Genotyping and linkage analysis
Genomic DNA from all (AcB62 Â CBA-Pk) F2 mice was extracted from tail biopsies by a standard proteinase K treatment protocol. 9 The genomic DNA was genotyped for a total of 130 microsatellite and SNP markers. Microsatellite markers were genotyped by a standard PCR-based method using (a-32 P) dATP labeling and separation on denaturing 6% polyacrylamide gels. SNP genotyping was performed at KBiosciences, UK (www.kbiosciences.co.uk) from a custom panel. Additional SNP genotyping was performed in house by standard PCR followed by fluorescence-based sequencing. QTL mapping was performed using Haley-Knott multiple regression analysis 25 or EM maximum likelihood algorithm.
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A two-dimensional scan was performed using the two-QTL model and empirical genome-wide significance was calculated by permutation testing (500 tests). All linkage analysis was performed using R/QTL.
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Results Susceptibility to P. chabaudi infection in PK-deficient AcB62 mice Screening a subset of 18 AcB/BcA strains initially identified AcB55 and AcB61 as highly resistant to P. chabaudi infection (low-peak parasitemia, 100% survival), despite their A/J susceptible background. 7 Subsequently, resistance in both AcB55 and AcB61 was shown to be caused by the same loss-of-function mutation at Pklr (Pklr I90N ). 13 This mutation occurred in the A/J-derived portion of chromosome 3 and likely represents an ancestral mutation that arose during the early stages of breeding in a common progenitor and was fixed in these strains (Supplementary Figure 1A) . We used restriction fragment length polymorphism to screen for the presence of Pklr I90N in the remaining AcB/BcA strains and identified AcB62 as carrying the mutation. The presence of Pklr I90N in AcB62 was validated by DNA sequencing of genomic DNA (Supplementary Figure 1B) . We infected AcB62 male and female mice, together with resistant AcB55 and susceptible A/J controls with 10 6 P. chabaudi i.p, followed parasitemia daily, and monitored survival ( Figure 1 ). Unlike AcB55/AcB61, AcB62 mice seemed to be susceptible to P. chabaudi; they experienced a rapid rise in parasitemia early during infection, which results in a peak parasitemia similar to that measured in susceptible A/J and significantly higher than PKdeficient AcB55 mice in males ( Figure 1a ) and females ( Figure 1b) . Despite the high parasite burden experienced by AcB62, 100% of females and 70% of males cleared parasitemia and survived the infection. To determine the mode of inheritance of the unique susceptibility phenotype, we generated independent F1 crosses between AcB62 and either AcB55 or AcB61. Infection of the F1 progeny by P. chabaudi identified susceptibility as dominant in these crosses. F1 mice displayed high and rapid peak parasitemia in males ( Figure 1c ) and in females (Figure 1d) , although for the latter the dominance was more evident in the (AcB62 Â AcB55) cross. We observed gender-specific differences in susceptibility in all strains. It has long been established that susceptibility to P.chabaudi is significantly affected by gender, with male mice showing greater mortality and higher parasite burdens. 28 This has been shown to be dependent on testosterone, as male castration improves infection outcome and testosterone administration to females increases susceptibility. [29] [30] [31] These results suggest that the strong malaria-protective effect of PK deficiency is modified by other genetic factors in AcB62, and that susceptibility in this strain is dominant.
PK deficiency-associated anemia and erythropoiesis in AcB62 Protection against malaria in AcB55 and AcB61 is associated with the phenotypic manifestations of PK deficiency, including anemia, shortened half-life of PKdeficient erythrocytes, and extramedullary erythropoiesis in spleen and liver.
11,16 Therefore, we investigated whether susceptibility to P. chabaudi in AcB62 may be due to absence or modification of Pklr I90N -induced pathophysiology (that is, incomplete expressivity of the mutant allele). For this, we carried out standard hematological profiling of AcB62, including a complete blood count and differential (Table 1) . AcB62 displays clear signs of anemia, with low total erythrocyte counts (5.1 Â 10 12 per l compared with 9.1 Â 10 12 per l for A/J controls) and low hemoglobin levels (91.3 g l À1 vs 137.0 g l À1 ) ( Table 1) , as well as increased numbers of peripheral blood reticulocytes (21.6%), compared with A/J controls (3.5%) ( Table 1) . These parameters suggest the presence of a slightly more severe anemia in AcB62 compared to that which we have reported earlier for AcB55 and AcB61. 11 Like AcB55, and as opposed to A/J controls, AcB62 mice show signs of compensatory erythropoietic activity in the spleen ( Figure 2 ) and liver (not shown). Splenomegaly was apparent and histological analysis revealed breakdown of normal splenic architecture and massive expansion of the red pulp in AcB62 (Figure 2a) , all known consequences of PK deficiency. 11 Compared with A/J, AcB62 and AcB55 showed elevated spleen cell counts (twofold to fourfold increase; Figure 2b) , and a higher fraction of CD71 þ /TER119 þ doubly positive erythroid precursors (Figure 2c ). Owing to an RBC lysis step of spleen cell suspensions performed before labeling, the percentage of erythroid precursor cells is likely under-represented, but nevertheless indicates higher levels of erythroid progenitors in the PK mutant strains compared with A/J mice. As a consequence of the expansion of the erythropoietic compartment of the spleen, AcB62 showed a significantly lower percentage of T cells (CD3 þ ) (Figure 2d ) although the absolute numbers of T cells were similar because of splenomegaly (data not shown). Together, this hematological profiling confirms that AcB62 displays all the hallmarks of PK-induced anemia and compensatory erythropoiesis.
Iron overload in AcB62 tissues
Hemolytic anemia is often accompanied by peripheral iron overload, particularly in liver and spleen. 32 Iron homeostasis is not only an integral part of erythropoiesis, but elevated iron stores can also modulate host response to a number of infections. 33 To determine whether malaria susceptibility in AcB62 is linked to an alteration in PK deficiency-associated iron overload in peripheral tissues, spleen and liver iron content was measured in AcB62 (Pklr I90N ), AcB55 (Pklr I90N ), and wild-type A/J mice (Figure 3) . PERL staining (iron-specific reagent) of A malaria susceptibility locus on chromosome 9 G Min-Oo et al liver sections showed significant reactivity (blue color) in both PK-deficient strains compared to a complete absence of staining in A/J (Figure 3a) . High magnification indicates that iron is highly concentrated in liver macrophages (Kupffer cells) of PK-deficient strains. Similarly, direct quantification of iron content from fresh liver and spleen extracts showed significantly elevated iron stores in both PK-deficient strains (Figure 3b ), compared with either A/J or a PK wild-type control strain (AcB51). Notably, AcB62 had even higher liver and splenic iron content than AcB55 (500 mg g À1 vs 350 mg g À1 in spleen; 1000 mg g À1 vs 550 mg g À1 in liver tissue). We also measured the tissue expression of various proteins that participate in iron homeostasis. Membrane or total fractions from spleen and liver extracts (two mice per strain) were prepared, followed by immunoblotting to detect levels of the TFR/CD71, heme oxygenase 1, ferroportin, and DMT1 (DMT1; measured in whole organ extracts). Levels of DMT1 and TFR showed strikingly higher levels in both PK-deficient AcB55 and AcB62 compared with A/J controls ( Figure 4a ). As both TFR and DMT1 are expressed at high levels in erythrocyte precursors, 34, 35 the increased expression of both proteins in spleen extracts of PK-deficient mice is in agreement with enhanced erythropoiesis detected in these mice (elevated TER119 þ /CD71 þ cells, Figure 2 ). Furthermore, elevated expression of heme oxygenase and ferroportin was noted in the livers of PK-deficient strains (AcB62 and AcB55). These results agree with the presence of iron in liver macrophages (Figure 3a) because of high iron recycling, and subsequently leading to iron overload as observed in Figure 3 . Taken together, these results verify that AcB62 mice, like AcB55, show similar manifestations of PK deficiency-induced anemia, including increased erythropoiesis, disrupted iron homeostasis, and tissue iron overload. These findings suggest that malaria susceptibility in AcB62 cannot be explained by altered expressivity of the Pklr-associated mutant phenotype.
QTL mapping in (AcB62 Â CBA-Pk) F2 mice The genetic control of malaria susceptibility in AcB62 was investigated in an informative F2 cross, in which all animals were fixed for Pklr deficiency. We crossed AcB62 to CBA/N-Pk slc (CBA-Pk), 15 a strain that carries a mutant allele at Pklr (Pklr 16 We previously found CBA-Pk slc mice to be highly resistant to P. chabaudi-induced blood-stage malaria. 16 In addition, the (AcB62 Â CBA-Pk slc ) F2 cross allowed us to identify possible gene effects localized to either B6 or A/J fragments fixed in AcB62. A total of 186 (AcB62 Â CBA-Pk slc )F2 mice were infected i.p. with 10 6 P.chabaudi, and the infection was monitored by measuring daily blood parasitemia in these mice. Owing to the poor breeding performance of (AcB62 Â CBA-Pk slc ) F1 animals, three separate batches of F2 animals were phenotyped in three experiments over an 18-month period. A typical distribution of peak parasitemia in AcB62 and CBA-Pk slc parental controls, as well as F1 and F2 mice, is shown in Figure 5a (batch 2). Owing to the intrinsic variation in the virulence of the P. chabaudi inoculum, a basic normalization procedure was used, subtracting the mean peak parasitemia in an infection batch and sex-dependent manner. We designated this as the 'corrected peak parasitemia' with the mean set at 0. The F2 population still displayed a normal and continuous distribution around the mean (Figure 5b ). Informative F2 mice were genotyped for 130 polymorphic markers (microsatellite and SNPs) across the genome. Gaps in the genome exist in regions where high degrees of similarity between the two strains precluded the identification of polymorphic alleles, for instance, on chromosome X. Multiple regression linkage analysis in R/QTL was performed across all chromosomes, using corrected peak parasitemia as a trait, for groups of males (n ¼ 114) and females (n ¼ 72) and for all mice together (Figure 5c ). This analysis identified a highly significant linkage on chromosome 9 and one weaker linkage on chromosome 3.
Additive effect of the chromosome 9 and 3 loci on peak parasitemia We further analyzed the significant QTL identified by initial linkage analysis in the (AcB62 Â CBA-Pk) cross. Genome-wide significance thresholds were determined by empirical permutation testing, consisting of 500 tests. The locus identified on chromosome 9 (peak LOD score ¼ 7.24) was highly significant (Po0.01 genome wide), with males showing much stronger linkage than female mice (Figure 6a ). The Bayesian 95% credible interval using peak parasitemia as a phenotype was determined to be 50.7-75 Mb. We have given this locus the temporary designation Char10 (Chabaudi resistance locus 10). The peak LOD score was identified at 59.7 Mb (for marker rs9_6; NCBI ID: rs3685575). Char10 is proximal to the P. chabaudi resistance locus, Char1, which has been previously localized around position 100 Mb 36, 37 ( Figure 6a ). Subsequent analysis of chromosome 9 using additional mice from a fourth batch of F2 mice (n ¼ 237 total; males ¼ 140, females ¼ 97) and a subset of microsatellite markers, increased the LOD score to 10.8 and decreased the 95% credible interval to 17 Mb, from 51.3 to 68.3 Mb (Supplementary Figure 2) . The locus identified on chromosome 3 maps to the Pklr region and may correspond to segregating mutant alleles in this F2 population. All F2 mice were PK deficient: either homozygous for the I90N mutation, the G338D mutation, or compound heterozygotes. Linkage at Pklr is significant (LOD score ¼ 3.7; Po0.05) with the effect attributed entirely to the male F2 mice (Figure 6b ). This may reflect a gender-specific effect on the penetrance or expressivity of the segregating mutant Pklr alleles. To examine the effect of the novel Char10 locus on parasitemia levels, we segregated the F2 mice on the basis of their genotype at the most significant marker on chromosome 9 (rs9_6; NCBI ID: rs3685575) as shown in Figure 6c . Here, the male and female mice are plotted together as the 'corrected peak parasitemia', which has been adjusted for gender. Mice carrying AcB62 alleles at Char10 have significantly higher parasitemia levels (Po0.0001; Mann-Whitney t-test) than those carrying CBA-Pkderived alleles, whereas heterozygous mice show intermediate levels. This suggests a co-dominant genetic effect for the chromosome 9 locus. We examined the contribution of both Char10 alleles and the chromosome 3 Pklr alleles (Figure 6d ), and they seem to have an additive effect on the peak parasitemia. F2 mice that carry AcB62-derived alleles at Char10 and are also homozygous for the Pklr I90N mutation show the highest parasitemia levels.
Discussion
We have used the AcB/BcA recombinant congenic strains to study the complex nature of susceptibility to blood-stage malaria in mice. So far, this approach has successfully identified two important genes, Pklr and Vanin. 13, 10 Screening the AcB/BcA strains led to the discovery that AcB62 also carries the protective Pklr I90N mutation yet shows a surprising response to P.chabaudi with rapid parasite replication and high parasite burdens at the peak of infection. Despite high levels of parasitemia, AcB62 mice did not succumb to infection, another unusual trait in animals that develop such high levels of peak parasitemia. Therefore, it seems that AcB62 mice have lost the early advantage of PK deficiency in dampening parasite replication during the initial stages of infection, but appear to recover from high blood parasitemia and anemia. We cannot determine whether both phenotypes are controlled by the same gene(s) in AcB62. AcB62 mice do display the manifestations of PK deficiency that are associated with malaria protection, namely, splenic red pulp expansion, reticulocytosis, and anemia. In addition, significant iron overload is evident in the spleen and liver, similar to other PK-deficient mice. 20 Using the peak parasitemia as a trait, we have uncovered a novel locus on chromosome 9, with highly significant linkage (LOD score ¼ 10.8; n ¼ 237), and a minimal predicted interval of B17 Mb. The strong linkage observed for Char10 (greatly above genome-wide Dimer TFR Figure 4 Elevated expression of iron-regulated proteins in spleen and liver of AcB55 and AcB62 mice. Proteins from spleen (a) and liver (b) extracts were separated by electrophoresis on an SDScontaining polyacrylamide gel followed by transfer to a membrane and immunoblotting for the presence of DMT1, transferrin receptor (TFR/CD71), heme oxygenase 1 (HO1), ferroportin (FPN), and vinculin (VCL; used as a loading control). DMT1 was detected in whole spleen extracts (a), with a DMT1 over-expressing cell lysate used as a positive control ( þ veCTR), whereas other proteins were detected in crude membrane extracts. The position and size of the molecular mass markers are indicated (in kilodaltons).
significance) suggests the presence of a major genetic factor influencing parasite replication. Several key cell populations and host response pathways are important for controlling initial replication of Plasmodium. An early pro-inflammatory response to rising blood parasitemia, including production of the cytokines IFNg, TNFa, and IL-12, is critical (reviewed in Malaguarnera and Musumeci 38 , Stevenson and Riley 39 ); however, this cytokine response has also been associated with pathogenesis in human infections.
40 CD4 þ T helper 1 cells also have a key function during the acute phase of infection and bridge the innate and adaptive responses. 39 Additionally, a protective role for various components of the innate immune response, particularly dendritic cells and NK cells, has been established. 41, 42 Many of the key host immune factors have been characterized using mouse models. For example, CD4 þ T-cell depleted mice show high levels of peak parasitemia and are subsequently unable to clear parasites during the chronic phase, 39 whereas IFNg knockout mice experience uncontrolled parasite replication and all mice succumb to hyper-parasitemia and anemia. 43, 44 Similarly, mice carrying a mutation in IRF-8 (BXH-2) are extremely susceptible to P. chabaudi. 45 Therefore, uncontrolled early parasite replication in the AcB62 strain could be linked to an impaired early inflammatory response and/or dampened polarization of the critical, early Th1 response. 46 The minimal Char10 region is large, B20 Mb; numerous genes associated with the innate or protective immune response map within Char10. These include Adam10, a factor important in thymocyte development, 47 CD276/B7-H3, a negative regulator of Th1 responses, 48 Csk, which has a role in T-cell maturation, 49 Pias1, an inhibitor of interferon signaling through STAT1, 50 and Pml, which has a well-established role in hematopoietic differentiation. 51 P. chabaudi is a mouse model of blood-stage parasite replication and Plasmodium replication can be influenced by the available pool of uninfected erythrocytes, and/or the integrity of the erythrocyte itself. Plasmodium species often display an invasion preference for erythrocytes of a certain age; this is regulated by specific ligand-receptor interactions 52 that have, to date, not been completely delineated. For example, P. vivax prefers to invade reticulocytes, which has been associated with the expression of two reticulocyte-binding proteins (PvRBP-1,-2) by this parasite, 53 but homologues of these proteins have now also been identified in most Plasmodium species. 54 P. falciparum does not seem to have a stage-specific preference for erythrocyte invasion, 54, 55 whereas P.chabaudi has been reported to prefer mature erythrocytes. 56 As a result, the age of available erythrocytes may have a role in the level of parasitemia experienced by the host, particularly in infection models in which parasitemia can be as high as B70% parasitized erythrocytes. 57 Genes involved in erythropoiesis, including maturation and additional aspects of turnover, as well as genes important for iron metabolism in general, may all be positional candidates for Char10. Additionally, mutations in erythrocyte proteins affecting either the erythrocyte cytoskeleton or intracellular energy metabolism are all known to influence malaria susceptibility. 5 These mutations are known to affect parasite invasion as well as uptake of infected and uninfected cells by phagocytic macrophages. 5 The Char10 minimal interval contains several genes associated with iron metabolism, and/or erythropoiesis, including: Ireb2, Pml, Aqp9, and Dapk2. Ireb2 regulates iron metabolism proteins at the post-transcriptional level and targeted deletion of this gene in the mouse results in bone marrow iron depletion, microcytic anemia, and neurodegeneration. 58 Interestingly, Aqp9, the erythrocyte glycerol channel, has been linked to P.berghei susceptibility with Aqp9 À/À mice showing increased survival; however, no differences in parasitemia were seen. 59 Dapk2 shows pro-apoptotic activity in erythroid precursors and has recently been shown to have an important function in erythroblast maturation. 60 The positional cloning of the gene responsible for the Char10 effect will involve the creation and characterization of congenic mouse strains carrying sub-fragments of the current 17 Mb interval defining the locus. This will be followed by the prioritization of positional candidates for DNA sequencing and construction and/or biological testing of loss of function alleles at these genes. Our study has identified a major locus controlling P.chabaudi replication in the context of PK deficiency. Corrected Parasitemia Figure 6 Additive effect of the chromosomes 3 and 9 (Char10) loci on peak parasitemia in P. chabaudi-infected (AcB62 Â CBA-Pk) F2 mice. LOD score traces for the chromosome 9 (Char10; a) and chromosome 3 (b) loci are shown for males, females, and both sexes together. The position of the previously mapped Char1 locus on chromosome 9 is indicated, as is the position of the Pklr gene on chromosome 3. Levels of genome-wide significance are indicated at P ¼ 0.01 and 0.05. The independent and combined effect of Char10 alleles (rs9_6 marker; peak LOD score) and Pklr alleles on peak parasitemia in P. chabaudi-infected (AcB62 Â CBA-Pk) F2 mice is shown (c, d).
